Related Topics:
Facility ID: 30603NRMCN1440O
Facility Name and Address: JANSSEN PHARMACEUTICALS INC. 1440 OLYMPIC DR ATHENS, GA 30601 Parent Company: JOHNSON & JOHNSON INC Industry: Medicinal and Botanical Manufacturing(325411) Reports: View TRI Facility profile report for this facility View TRI Form R submissions by this facility |
|
*You can navigate within the map with your mouse. |
Production Related Waste Management for Selected Facility
Chart Options: |
Waste Management by Chemical -
Chart Options: |
Pollution Prevention Activities for Selected Facility
List all P2 activities for this facility
Chemical Name | P2 Report | 5-Year Waste Trend | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pyridine | 21% | B | B | B | B | B | P2 | P2 | P2 | P2 | P2 | ||||||||||||||||
n-Butyl alcohol | 100+% | B | B | B | |||||||||||||||||||||||
Ethylbenzene | NA | P2 | P2 | P2 | P2 | P2 | |||||||||||||||||||||
Triethylamine | 100+% | B | B | ||||||||||||||||||||||||
Ammonia | -18% | B | B | B | B | B | |||||||||||||||||||||
Xylene (mixed isomers) | NA | P2 | P2 | P2 | P2 | P2 | |||||||||||||||||||||
Methyl ethyl ketone | NA | P2 | P2 | P2 | P2 | P2 | P2 | ||||||||||||||||||||
Cyclohexane | NA | B | B | B | |||||||||||||||||||||||
Toluene | 37% | B | B | B | B | B | P2 | P2 | P2 | ||||||||||||||||||
N,N-Dimethylformamide | NA | B | B | P2 | P2 | P2 | P2 | P2 | P2 | ||||||||||||||||||
Methanol | -21% | B | B | B | B | B | P2 | P2 | P2 | P2 | P2 | P2 | |||||||||||||||
Ethylene glycol | NA | P2 | |||||||||||||||||||||||||
Acetonitrile | 100+% | B | B | B | B | B | B |
- P2: P2 information provided on Form R
- O: Other Environmental Practices
- No P2: No P2 information provided on Form R
- B: Barriers reported
- -: Form R not submitted